- £1.47bn
- -£143.33m
- £734.70m
- 54
- 97
- 53
- 81
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 341 | 451 | 579 | 733 | 730 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 326 | 380 | 583 | 703 | 681 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 209 | 260 | 465 | 532 | 374 |
Provision for Income Taxes | |||||
Net Income After Taxes | 159 | 196 | 345 | 410 | 283 |
Net Income Before Extraordinary Items | |||||
Net Income | 159 | 196 | 345 | 410 | 283 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 153 | 191 | 340 | 410 | 283 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.563 | 0.518 | 0.757 | 0.932 | 0.671 |
Dividends per Share | |||||
Special Dividends per Share |